Cleared Traditional

K893691 - EMDS CREATINE KINASE ITEM NIMBER 65411

K893691 is an FDA 510(k) clearance for EMDS CREATINE KINASE ITEM NIMBER 65411, manufactured by Diagnostic Systems. The device is a Class 2 Chemistry device with product code CGS cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K893691 · Diagnostic Systems · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1989
Decision
107d
Days
Class 2
Risk

K893691 is an FDA 510(k) clearance for the EMDS CREATINE KINASE ITEM NIMBER 65411. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Diagnostic Systems (Gibbstown, US). The FDA issued a Cleared decision on August 31, 1989 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Systems devices

FDA 510(k) Submission Details - K893691

510(k) Number K893691 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 1989
Decision Date August 31, 1989
Days to Decision 107 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 88d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGS Device Classification - Class 2, Special Controls

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 118
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K893691.
CREATINE KINASE-MB TEST (MB-DS) ITEM #67655
K902483 · Em Diagnostic Systems, Inc. · Jul 1990
COULTER CK (CREATINE KINASE) REAGENT
K901267 · Coulter Corp. · May 1990
CREATINE KINASE FOR MANUAL/AUTOMATED APPLICATIONS
K894715 · Catachem, Inc. · Nov 1989
REP(TM) CK-2 STAT KIT, CAT. NO. 3074
K893007 · Helena Laboratories · Jul 1989
BECKMAN PARAGON(TM) CREATINE KINASE ISOENZYME
K893269 · Beckman Instruments, Inc. · Jul 1989
ROCHE(R) CARDIOSCREEN-CK
K891462 · Roche Diagnostic Systems, Inc. · May 1989